DPDPE
Overview[edit]
DPDPE is a synthetic opioid peptide that acts as a selective delta-opioid receptor agonist. It is primarily used in research to study the function and pharmacology of delta-opioid receptors, which are one of the three main types of opioid receptors, the others being mu and kappa.
Chemical Structure[edit]
DPDPE stands for D-Pen2, D-Pen5-enkephalin, which indicates that it is a modified form of the naturally occurring enkephalin peptides. The structure of DPDPE includes two D-penicillamine residues, which contribute to its high selectivity and affinity for delta-opioid receptors.
Mechanism of Action[edit]
DPDPE binds to the delta-opioid receptors, which are G protein-coupled receptors located primarily in the central nervous system and peripheral nervous system. Upon binding, DPDPE activates these receptors, leading to a cascade of intracellular events that result in analgesic effects, among other physiological responses.
Pharmacological Effects[edit]
The activation of delta-opioid receptors by DPDPE can produce analgesia, although it is generally less potent than the analgesia produced by mu-opioid receptor agonists. Delta-opioid receptor activation has also been associated with mood modulation and potential antidepressant effects. However, the precise role of delta-opioid receptors in these processes is still under investigation.
Research Applications[edit]
DPDPE is widely used in pharmacology and neuroscience research to explore the role of delta-opioid receptors in pain modulation, mood regulation, and other physiological processes. It serves as a valuable tool for understanding the distinct functions of different opioid receptor subtypes.
Safety and Toxicity[edit]
As a research chemical, DPDPE is not intended for human or veterinary use. Its safety profile in humans is not well-established, and it should be handled with caution in laboratory settings.
